Novo Nordisk Retained Earnings (Accumulated Deficit) 2010-2025 | NVO
Novo Nordisk retained earnings (accumulated deficit) for the quarter ending March 31, 2025 were $19.376B, a 34.35% increase year-over-year.
- Novo Nordisk retained earnings (accumulated deficit) for 2024 were $20.945B, a 37.59% increase from 2023.
- Novo Nordisk retained earnings (accumulated deficit) for 2023 were $15.223B, a 33.4% increase from 2022.
- Novo Nordisk retained earnings (accumulated deficit) for 2022 were $11.411B, a 0.39% decline from 2021.